ClinicalTrials.Veeva

Menu

ML Models for Predicting Postoperative Peritoneal Metastasis After Hepatocellular Carcinoma Rupture

C

Chen Xiaoping

Status

Completed

Conditions

Peritoneal Metastasis

Treatments

Other: Peritoneal Metastasis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This study aimed to address the issue of peritoneal metastasis (PM) following the rupture of hepatocellular carcinoma (HCC) and its adverse impact on patient prognosis. Clinical data from 522 patients with ruptured HCC who underwent surgery at seven different medical centers were collected and analyzed. Machine learning models were employed for analysis and prediction.

Enrollment

522 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:(1) HCC confirmed by pathologists (2) two preoperative imaging findings suggestive of tumor rupture (3) R0 resection (4) first tumor detection -

Exclusion Criteria:(1) previous antitumor therapy (2) combination of other types of tumors (3) incomplete clinical data

Trial design

522 participants in 2 patient groups

Training cohort
Description:
All cases were randomly grouped according to 7:3, with 70% defined as the training group
Treatment:
Other: Peritoneal Metastasis
Validation cohort
Description:
All cases were randomly grouped according to 7:3, with 30% defined as the validation group
Treatment:
Other: Peritoneal Metastasis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems